The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number of already approved and marketed drugs are being tested for repurposing, including Favipiravir. We aim to investigate the efficacy and safety of Favipiravir i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanipour, Soheil, Arab-Zozani, Morteza, Amani, Bahman, Heidarzad, Forough, Fathalipour, Mohammad, Martinez-de-Hoyo, Rudolph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155021/
https://www.ncbi.nlm.nih.gov/pubmed/34040117
http://dx.doi.org/10.1038/s41598-021-90551-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155021/
https://www.ncbi.nlm.nih.gov/pubmed/34040117
http://dx.doi.org/10.1038/s41598-021-90551-6

Ejemplares similares